Medicaid supplement rebate agreement

The New York Department of Health has awarded contract X043773 to Catalyst Pharmaceuticals Inc., effective July 1, 2026, through June 30, 2029. This three-year contract represents an engagement with a pharmaceutical manufacturer, though the specific products and services to be delivered are not detailed in the available contract documentation. Catalyst Pharmaceuticals Inc. serves as the prime contractor responsible for fulfilling the Department of Health's requirements during the performance period.

The contract documentation does not specify a definitive contract amount, annual value, or cumulative value, presenting insufficient financial data to assess the monetary scope of this engagement. Similarly, the specific geographic locations of performance, detailed service descriptions, and functional deliverables cannot be determined from the materials provided. Interested parties requiring additional contract details should consult directly with the New York Department of Health or access the complete contract file through official state procurement channels.